Logo for InMed Pharmaceuticals Inc

InMed Pharmaceuticals Investor Relations Material

Latest events

Logo for InMed Pharmaceuticals Inc

Q4 2022

InMed Pharmaceuticals
Logo for InMed Pharmaceuticals

Q2 2024

13 Feb, 2024
Logo for InMed Pharmaceuticals

Corporate Presentation

29 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from InMed Pharmaceuticals Inc

Access all reports
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. It uses its drug development programs to treat diseases with high unmet medical need. The company's product pipelines include Epidermolysis Bullosa, Glucocerebrosidase Deficiency, Ocular Scarring, and Transdermal Cannabinoid delivery system. Its platform technology includes Biosynthesis process for natural plant-based cannabinoids, Bioinformatics databases to assess the pharmacological activity of existing and novel cannabinoids, and Drug delivery platforms that provide targeted therapeutic options. The company was formerly known as InMed BioPharma Inc. and changed its name to InMed Pharmaceuticals Inc. in December 2016. InMed Pharmaceuticals Inc. was founded in 2011 and is based in Vancouver, Canada.